Monica R. Muppidi

Hematology

234 E 149th St Ste 9871
Bronx, NY 10451

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

HSR25-146: How Mental Health and Substance Use Drive Cancer Disparities in Urban Communities.

HSR25-146: How Mental Health and Substance Use Drive Cancer Disparities in Urban Communities.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: March 28, 2025

A Case of Amoxicillin-Induced Drug Reaction With Eosinophilia and Systemic Symptoms (Dress) Syndrome Associated With Significant Reactive Hypereosinophilia (HE): A Case Report.

A Case of Amoxicillin-Induced Drug Reaction With Eosinophilia and Systemic Symptoms (Dress) Syndrome Associated With Significant Reactive Hypereosinophilia (HE): A Case Report.

Journal: Cureus

Published: July 10, 2023

Rasburicase in treating tumor lysis syndrome: An umbrella review.

Rasburicase in treating tumor lysis syndrome: An umbrella review.

Journal: Cancer pathogenesis and therapy

Published: May 26, 2023

Severe Pancytopenia After COVID-19 Revealing a Case of Primary Bone Marrow Diffuse Large B Cell Lymphoma.

Severe Pancytopenia After COVID-19 Revealing a Case of Primary Bone Marrow Diffuse Large B Cell Lymphoma.

Journal: The American journal of case reports

Published: September 24, 2022

An interactive mobile application versus an educational booklet to promote job retention in women undergoing adjuvant chemotherapy for breast cancer: a randomized controlled trial.

An interactive mobile application versus an educational booklet to promote job retention in women undergoing adjuvant chemotherapy for breast cancer: a randomized controlled trial.

Journal: Trials

Published: March 13, 2022

Continuing cancer care delivery during the peak of COVID-19 in the Bronx, New York: experience from a public teaching hospital.

Continuing cancer care delivery during the peak of COVID-19 in the Bronx, New York: experience from a public teaching hospital.

Journal: Archives of medical science : AMS

Published: April 19, 2021

Cladribine, cytarabine, and GCSF with and without mitoxantrone (CLAG ± M) is highly effective for poor risk acute myeloid leukemia with adverse karyotype and prior hypomethylating therapy.

Cladribine, cytarabine, and GCSF with and without mitoxantrone (CLAG ± M) is highly effective for poor risk acute myeloid leukemia with adverse karyotype and prior hypomethylating therapy.

Journal: Leukemia & lymphoma

Published: February 17, 2021

Decitabine and Sorafenib Therapy in FLT-3 ITD-Mutant Acute Myeloid Leukemia.

Decitabine and Sorafenib Therapy in FLT-3 ITD-Mutant Acute Myeloid Leukemia.

Journal: Clinical lymphoma, myeloma & leukemia

Published: December 11, 2014

Showing 1-8 of 8

Last Updated: 09/26/2026